Drugs / Milk Polar Lipid-Rich Dairy Powder
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05700916 | Oct 2023 → May 2026 overdue | hyperlipidemia, obesity disorder | University of Connecticut | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Milk Polar Lipid-Rich Dairy Powder | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05700916 ↗ |
| Route | Oral | “Participants will consume either a control dairy beverage (n = 65) or an MPL-rich dairy beverage (n = 65) for 8 weeks.” NCT05700916 ↗ |